Objective
to investigate the safety and clinical efficacy of ultra thin strut biodegradable polymer SES compared to thin strut durable-polymer EES in patients with STEMI
Study
multicentre, prospective, single blind randomised trial
Population
patients with STEMI referred for primary PCI
Endpoints
target lesion failure as cardiac death, target vessel MI, clinical indicated TL revascularisation during 12 month follow-up
Conclusion
biodegradable polymer SES treatment was superior to durable polymer EES treatment in patients with STEMI
Iglesias et al. Lancet. 2019;394:1243-53
